ArticleClinical cancer research : an official journal of the American Association for Cancer Research2025

The Bi-steric, mTORC1-Selective Inhibitor, RMC-5552, in Advanced Solid Tumors: A Phase 1 Trial.

Alison M Schram et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.